Search Results 561-570 of 15749 for Homocysteine
Mayo Clinic's Antibody Hybridoma Core provides hybridoma monoclonal antibody production services to investigators.
Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.
The purpose of this study is to evaluate the effectiveness, safety and tolerability of ASP0367 in participants with Primary Mitochondrial Myopathy (PMM).
MGUS is a condition in which altered plasma cells make monoclonal proteins. MGUS may increase the risk of certain blood cancers and related conditions.
At Mayo Clinic, Cornelius A. Thiels, D.O., M.B.A., conducts quality improvement and surgical outcomes research focused on pancreatic, colon and other ...
In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in the ...
SUMMARY. J Kyle Bohman, M.D., is particularly interested in researching diseases that he sees in his clinical practice, both in the operating theater and in ...
About this study. The overall objective is to develop a clinical data registry that can be used to facilitate research with the ultimate goal of reducing ...
Mayo Clinic's Cellular and Molecular Physiology of Gastrointestinal Disorders Lab led by Gianrico Farrugia, M.D., studies gastrointestinal motility in cells ...
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.